Article Details
Retrieved on: 2024-11-20 14:54:48
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article describes Voyager Therapeutics' development of VY1706, a gene therapy candidate using adeno-associated virus technology targeting tau protein reduction for Alzheimer's disease. It highlights advancements in applied genetics, gene delivery, and medical biotechnology.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here